Endothelin receptors: What's new and what do we need to know?

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 2, 2010, Pages

  Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Functional selectivity; Heterodimerization

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; AMBRISENTAN; ATRASENTAN; DARUSENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; IR 2500; IRL 2500; MACITENTAN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N (3 METHOXY 5 METHYL 2 PYRAZINYL) 2 [4 (1,3,4 OXADIAZOL 2 YL)PHENYL] 3 PYRIDINESULFONAMIDE; RES 7011; SARAFOTOXIN S6C; SITAXSENTAN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; UNCLASSIFIED DRUG;

DIMERIZATION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOTHELIN-1; ENDOTHELINS; HUMANS; LIGANDS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 75449108821     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00584.2009     Document Type: Review

References (123)

1. 2 receptor functional heterodimerization. Hypertension 48: 316-322, 2006.
2. 2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J Mol Neurosci 26: 185-192, 2005.
3. B receptors. Br J Pharmacol 133: 927-935, 2001.
4. Angerio AD. Endothelin-1-mediated inflammation in acute renal failure. Crit Care Nurs Q 29: 152-156, 2006.
5. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
6. Armstead WM. Endothelins and the role of endothelin antagonists in the management of posttraumatic vasospasm. Curr Pharm Des 10: 2185-2192, 2004.
7. B binding domains using ET-derived photoprobes. Biochimie 90: 918-929, 2008.
8. Bagnato A, Rosano L. The endothelin axis in cancer. Int J Biochem Cell Biol 40: 1443-1451, 2008.
9. Barton M, Yanagisawa Endothelin M. 20 years from discovery to therapy. Can J Physiol Pharmacol 86: 485-499, 2008.
10. B receptors reverse the ET-1-induced sustained increase of cytosolic and nuclear calcium in human aortic vascular smooth muscle cells. Can J Physiol Pharmacol 86: 546-556, 2008.
11. Black SM, Kumar S, Wiseman D, Ravi K, Wedgwood S, Ryzhov V, Fineman JR. Pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxide. Clin Hemorheol Microcirc 37: 111-120, 2007.
12. Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76: 8-18, 2007.
13. Braasch I, Volff JN, Schartl M. The endothelin system: evolution of vertebrate-specific ligand-receptor interactions by three rounds of genome duplication. Mol Biol Evol 26: 783-789, 2009.
14. Bulenger S, Marullo S, Bouvier M. Emerging role of homo- and heterodimerization in G protein coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26: 131-137, 2005.
15. Cameron IT, Bacon CR, Collett GP, Davenport AP. Endothelin expression in the uterus. J Steroid Biochem Mol Biol 53: 209-214, 1995.
16. Cernacek P, Stewart DJ, Monge JC, Rouleau JL. The endothelin system and its role in acute myocardial infarction. Can J Physiol Pharmacol 81: 598-606, 2003.
17. Chauhan BC. Endothelin and its potential role in glaucoma. Can J Ophthalmol 43: 356-360, 2008.
18. Clarke WP, Bond RA. The elusive nature of intrinsic efficacy. Trends Pharmacol Sci 19: 270-276, 1998.
19. B receptors expressed in HEK 293 cells. Exp Biol Med (Maywood) 231: 746-751, 2006.
20. Damon DH. Endothelin and post-ganglionic sympathetic neurons. Clin Exp Pharmacol Physiol 26: 1000-1003, 1999.
21. Davenport AP. International union of pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 54: 219-226, 2002.
22. Davenport AP, Maguire JJ. Endothelin. Handb Exp Pharmacol 176: 295-329, 2006.
23. Ducancel F. Endothelin-like peptides. Cell Mol Life Sci 62: 2828-2839, 2005.
24. Delarue C, Conlon JM, Remy-Jouet I, Fournier A, Vaudry H. Endothelins as local activators of adrenocortical cells. J Mol Endocrinol 32: 1-7, 2004.
25. Devi LA. G-protein coupled receptor dimers in the lime light. Trends Pharmacol Sci 21: 324-329, 2000.
26. D'Orleans-Just P, Labonte J, Bkaily G, Choufani S, Plante M, Honore JC. Function of the endothelin (B) receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther 95: 221-238, 2002.
27. 2 receptors in plasma membrane. Biochemistry 45: 8751-8759, 2006.
28. Evans NJ, Walker JW. Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J 95: 483-492, 2008.
29. 2+ signaling and delayed internalization associated with endothelin receptor heterodimers linked through PDZ finger. Can J Physiol Pharmacol 86: 526-535, 2008.
30. Fecteau MH, Honore JC, Plante M, Labote J, Rae GA, D'Orleans-Juste Pedro. Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo. Hypertension 46: 87-92, 2005.
31. Feldstein C, Romero C. Role of endothelins in hypertension. Am J Ther 14: 147-153, 2007.
32. B receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi. Br J Pharmacol 117: 959-999, 1996.
33. Gershon MD. Endothelin and the development of the enteric nervous system. Clin Exp Pharmacol Physiol 26: 985-988, 1999.
34. Gouldson PR, Higgs C, Smith RE, Dean MK, Gkoutos GV, Reynolds CA. Dimerization and domain swapping in G-protein-coupled receptors: a computational study. Neuropsychopharmacol 23, Suppl 4: S60-S77, 2000.
35. Granger JP, Abram S, Stec D, Chandler D, LaMarca B. Endothelin, the kidney and hypertension. Curr Hypertens Rep 8: 298-303, 2006.
36. Gregan B, Jurgensen J, Papsdorf G, Furkert J, Schaefer M, Beyermann M, Rosenthal W, Oksche A. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279: 27679-27687, 2004.
37. Grimshaw MJ. Endothelins and hypoxia inducible factor in cancer. Endocr Relat Cancer 14: 233-244, 2007.
38. Guise TA, Yin JJ, Mohammad KS. Role of endothelin-1 in osteoblastic bone metastases. Cancer Suppl 97: 779-784, 2003.
39. Gurevich VV, Gurevich EV. How and why do GPCRs dimerize? Trends Pharmacol Sci 29: 234-240, 2008.
40. 1D adrenergic receptor form a single functional entity. Mol Pharmacol 69: 45-55, 2006.
41. Hans G, Deseure K, Adriaensen H. Endothelin-1 induced pain and hyperalgesia: a review of pathophysiology, clinical manifestations and future therapeutic options. Neuropeptides 42: 119-132, 2008.
42. B receptor heterodimer. Cell Mol Neurobiol 22: 207-226, 2002.
43. Hinojosa-Laborde C, Lange DL. Endothelin regulation of adrenal function. Clin Exp Pharmacol Physiol 26: 995-999, 1999.
44. Holtke C, Waldeck J, Kopka K, Heindel W, Schober O, Schaffers M, Bremer C. Biodistribution of a nonpeptidic fluorescent endothelin A receptor imaging probe. Mol Imaging 8: 27-34, 2009.
45. Huang SC. Endothelin receptor in gastrointestinal smooth muscle. Curr Protein Pept Sci 6: 547-557, 2005.
46. B receptors. Regul Pept 117: 179-186, 2004.
47. Hyndman KA, Miyamoto MM, Evans DH. Phylogeny, taxonomy, and evolution of the endothelin receptor gene family. Mol Phylogen Evol 52: 677-687, 2009.
48. Imai Y, Soda M, Inoue H, Hatori N, Mizuno Y, Takahashi R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105: 891-902, 2001.
49. Inscho EW, Imig JD, Cook AK, Pollock DM. ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin. Br J Pharmacol 146: 1019-1026, 2005.
50. Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vas Health Risk Manag 4: 1061-1068, 2008.
51. Kaneko Y, Herrera VLM, Didishvilli T, Ruiz-Opazo N. Sex-specific effects of dual ET-1/ANG II receptor (DEAR) variants in Dahl saltsensitive hypertension rat model. Physiol Genomics 20: 157-164, 2005.
52. Karne S, Jayawickreme CK, Lerner MR. Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J Biol Chem 268: 19126-19133, 1933.
53. Kenakin T. Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72: 1393-1401, 2007.
54. Kenakin T. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7 TM receptors. Trends Pharmacol Sci 28: 407-415, 2007.
55. Khan ZA, Chakrabarti S. Endothelins in chronic diabetic complications. Can J Physiol Pharmacol 81: 622-634, 2003.
56. Khodorova A, Montmayeur JP, Strichartz G. Endothelin receptors and pain. J Pain 10: 4-28, 2009.
57. 2+ stores. J Cell Sci 121: 186-195, 2008.
58. Kohan DE. Endothelins: renal tubule synthesis and actions. Clin Exp Pharmacol Physiol 23: 337-344, 1996.
59. Kumar CS, Nuthulaganti P, Pullen M, Nambi P. Novel endothelin receptors in the follicular membranes of Xenopus laevis oocytes mediate calcium responses by signal transduction through gap junctions. Mol Pharmacol 44: 153-157, 1993.
60. Lam HC, Lee JK, Lu CC, Chu CH, Chuang MJ, Wang MC. Role of endothelin in diabetic retinopathy. Curr Vasc Pharmacol 1: 243-250, 2003.
61. Lange M, Pagotto U, Renner U, Arzberger T, Oeckler R, Stalla GK. The role of endothelins in the regulation of pituitary function. Exp Clin Endocrinol Diabetes 110: 103-112, 2002.
62. Laplante MA, de Champlain J. The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase. Can J Physiol Pharmacol 84: 21-28, 2006.
63. Lariviere R, Lebel M. Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol 81: 607-621, 2003.
64. B. J Pept Sci 15: 479-491, 2009.
65. LeMarca BD, Alexander BT, Gilbert JS, Ryan MJ, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med 5: S133-S138, 2008.
66. Levoye A, Dam J, Aoub MA, Guillame JL, Jockers R. Do orphan G protein coupled receptor have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep 7: 1094-1098, 2006.
67. B receptors in venous and arterial smooth muscle. Eur J Pharmacol 287: 279-285, 1995.
68. Makita T, Sucov HM, Gariepy CE, Yanagisawa M, Ginty DD. Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons. Nature 452: 759-763, 2008.
69. 2+-mobilizing endothelin receptors in C6 gloma cells. Physiol Res 51: 73-78, 2002.
70. Mallat A, Lotersztajn S. Multiple hepatic functions of endothelin-1: physiopathological relevance. J Hepatol 25: 405-413, 1996.
71. Marazziti D, Golini E, Gallo A, Lombardi MS, Matteoni R, Tocchini-Valentini GP. Cloning of GPR37, a gene located on chromosome 7 encoding a putative G protein coupled peptide receptor, from a human frontal brain EST library. Genomics 45: 68-77, 1997.
72. Marinissen JJ, Gutkind JS. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368-376, 2001.
73. Masaki T, Ninomiva H, Sakamoto A, Okamoto Y. Structural basis of the function of endothelin receptor. Med Cell Biochem 190: 153-156, 1999.
74. Masaki T, Vane JR, Vanhoutte PM. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev 46: 137-142, 1994.
75. Meiden R, Levy N. The ovarian endothelin network: an evolving story. Trends Endocrinol Metab 18: 379-385, 2007.
76. Mencarelli M, Pecorreli A, Carbotti P, Valacchi G, Grasso G, Muscetoola M. Endothelin receptor A expression in human inflammatory cells. Regul Pept 158: 1-5, 2009.
77. Michel RP, Langleben D, Dupuis J. The endothelin system in pulmonary hypertension. Can J Physiol Pharmacol 81: 542-554, 2003.
78. B receptors in rat isolated small mesenteric arteries. Br J Pharmacol 120: 1376-1382, 1997.
79. Minneman KP. Heterodimerization and surface localization of G protein coupled receptor. Biochem Pharmacol 73: 1043-1050, 2007.
80. Mizuguchi T, Nishiyama M, Moroi K, Tanaka H, Saito T, Masuda Y, Masaki T, de Wit D, Yanagisawa M, Kimura S. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br J Pharmacol 120: 1427-1430, 1997.
81. Moe GW, Rouleau JL, Nguyen QT, Cernacek P, Stewart DJ. Role of endothelins in congestive heart failure. Can J Physiol Pharmacol 81: 588-597, 2003.
82. Mortensen LH. Endothelin and the central and peripheral nervous systems: a decade of endothelin research. Clin Exp Pharmacol Physiol 26: 980-984, 1999.
83. Mullol J, Picado C. Endothelin in nasal mucosa: role in nasal function and inflammation. Clin Exp Allergy 30: 172-177, 2000.
84. 2+ signaling in endothelin-1 in rat aortic smooth muscle cells. J Cardiovasc Pharmacol 31: S199-S202, 1998.
85. Nelson J, Bagnato A, Battistini B, Nisen P. The endothelin axis: emerging role in cancer. Nat Rev Cancer 3: 110-116, 2003.
86. Neuhofer W, Gulberg V, Gerbes AL. Endothelin and endothelin receptor antagonism in portopulmonary hypertension. Eur J Clin Invest 36: 54-61, 2006.
87. Neuhofer W, Pittrow D. Role of endothelin and endothelin receptor antagonists in renal disease. Eur J Clin Invest 36: 78-88, 2006.
88. Ohlstein EH, Elliott JD, Feuerstein GZ, Ruffolo RR. Endothelin receptors: receptor classification, novel receptor antagonists, and potential therapeutic targets. Med Res Rev 16: 365-390, 1996.
89. Pate MA, Chester AH, Brown TJ, Roach AG, Yacoub MH. Atypical antagonism observed with BQ-123 in human saphenous vein. J Cardiovasc Pharmacol 31, Suppl 1: S172-S174, 1998.
90. Patocka J, Merka V, Hrdina V, Hrdina R. Pharmacological potential of endothelin receptors agonists and antagonists. Acta Medica 48: 67-73, 2005.
91. Pollock DM, Keith TL, Highsmith RF. Endothelin receptors and calcium signaling. FASEB J 9: 1196-1204, 1995.
92. 2-adrenergic receptors. J Pharmacol Exp Ther 318: 974-981, 2006.
93. Richter CM. The role of endothelin in chronic renal failure- developments in renal involvement. Rheumatology 45: iii36 -iii38, 2006.
94. Rosano L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A, Salvati E, Nicotra MR, Natali PG, Bagnato A. β-arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invastion and metastasis. Proc Natl Acad Sci USA 106: 2806-2811, 2009.
95. Rossi GP, Andreis PG, Colonna S, Albertin G, Aragona F, Belloni AS, Nussdorfer GG. Endothelin-1[1-31]: a novel autocrine-paracrine regulator of human adrenal cortex secretion and growth. J Clin Endocrinol Metab 87: 322-328, 2002.
96. Rossi GP, Belloni AS, Nussdorfer GG, Pessina AC. Endothelin and the adrenal gland. J Cardiovasc Pharmacol 35: S17-S20, 2000.
97. Ruiz-Opazo N, Hirayam K, Akimoto K, Herrera VLM. Molecular characterization of a dual endothelin-1/angiotensin II receptor. Mol Med 4: 96-108, 1998.
98. Russell FD, Molenaar P. The human heart endothelin system: ET-1 synthesis, storage, release and effect. Trends Pharmacol Sci 21: 353-359, 2000.
99. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kmura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature 348: 732-735, 1990.
100. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13: 103-108, 1992.
101. Sauvageau S, Thorin E, Caron A, Dupuis J. Evaluation of endothelin-1-induced pulmonary vasoconstriction following myocardial infarction. Exp Biol Med (Maywood) 231: 840-846, 2006.
102. Sauvageau S, Thorin E, Caron A, Dupuis J. Endothelin-1-induced pulmonary vasoreactivity is regulated by ETA and ETB receptor interactions. J Vasc Res 44: 375-381, 2007.
103. Schinelli S. Pharmacology and physiopathology of the brain endothelin system: an overview. Curr Med Chem 13: 627-638, 2006.
104. B receptors in cardiovascular disease. Ann Rev Pharmacol Toxicol 47: 731-759, 2007.
105. Sexton PM, Morfis M, Tilakaratne N, Hay DL, Udawela M, Christopoulos G, Christopoulos A. Complexing receptor pharmacology: modulation of family B G protein-coupled receptors by RAMPs. Ann NY Acad Sci 1070: 90-104, 2006.
106. 2 receptor gene is a target of angiotensin II type 1 receptor signaling. J Am Soc Nephrol 18: 1140-1149, 2007.
107. Shyamala V, Moulthrop TH, Stratto-Thomas J, Takamp-Olson P. Two distinct human endothelin B receptors generated by alternative splicing from a single gene. Cell Mol Biol Res 40: 285-296, 1994.
108. Sticherling M. The role of endothelin in connective tissue diseases. Rheumatology 45: iii8 -iiii10, 2006.
109. Sokolvsky M. Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol Ther 68: 435-471, 1995.
110. Sokolovsky M. Endothelin receptor heterogeneity, G-proteins, and signaling via camp and cGMP cascades. Cell Mol Neurobiol 15: 561-570, 1995.
111. 2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. Proc Natl Acad Sci USA 101: 1548-1553, 2004.
112. Tostes RC, Fortes ZB, Callera GE, Montezano AC, Touyz RM, Webb RC, Carvalho MH. Endothelin, sex and hypertension. Clin Sci 114: 85-97, 2008.
113. Touyz RM, Schiffrin EL. Role of endothelin in human hypertension. Can J Physiol Pharmacol 81: 533-541, 2003.
114. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320: 1-13, 2007.
115. Violin JD, Lefkowtiz RJ. β-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28: 416-422, 2007.
116. Von Websky K, Heiden S, Pfab T, Hocher B. Pathophysiology of the endothelin system-lessons from genetically manipulated animal models. Eur J Med Res 28: 1-6, 2009.
117. Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, Portoghese PS, Whistler JL. A heterodimer-selective agonists shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci USA 102: 9050-9055, 2005.
118. Watts SW, Priestley JRC, Thompson JM. Serotonylation of vascular proteins important to contraction. PLoS One 4: e5682, 2009.
119. Wilkie TM. Treasures throughout the life-cycle of G protein coupled receptors. Trends Pharmacol Sci 22: 396-397, 2001.
120. Wilson SJ, Dowling JK, Zhao L, Carnish E, Smyth EM. Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization. Arterioscler Thromb Vasc Biol 27: 290-296, 2007.
121. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
122. Yu C, Yang Z, Ren H, Zhang Y, Han Y, He D, Lu Q, Wang X, Wang X, Yang C, Asico LD, Hopfer U, Eisner GM, Jose PA, Zeng C. D3 dopamine receptor regulation of ETB receptors in renal proximal tubule cells from WKY and SHRs. Am J Hypertens 22: 877-883, 2009.
123. Zhang A, Liu Z, Kan Y. Receptor dimerization-rationale for the design of bivalent ligands. Curr Top Med Chem 7: 3343-345, 2007.